ATI-1025

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameATI-1025

Drug Alias NameRhenium-186-BMEDA-BTanticancer radiotherapeutics (Azaya)186Re-BMEDA-BTAzaya Liposomal Encapsulated Radiation TherapyBMEDA-BT [186Re] +[7]

ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsGliomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUT Health San Antonio

China Registration ClassN/A

Develop Information

Active CompaniesUT Health San Antonio

Inactive CompaniesAzaya Therapeutics Inc

Active IndicationsGlioma

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A